title: [Current status of bone/cartilage tissue engineering towards clinical applications].
abstract: Osteo/chondrogenic differentiation capabilities are seen after in vivo implantation of mesenchymal stem cells (MSCs), which are currently used for the patients having bone/cartilage defects. Importantly, the differentiation capabilities are induced by culturing technology, resulting in in vitro bone/cartilage formation. Especially, the in vitro bone tissue is useful for bone tissue regeneration. For cartilage regeneration, culture expanded chondrocytes derived from patient's normal cartilage are also used for the patients having cartilage damages. Recently, the cultured chondrocytes embedded in atelocollagen gel are obtainable as tissue engineered products distributed by Japan Tissue Engineering Co. Ltd. The products are available in the well-regulated hospitals by qualified orthopedic surgeons. The criteria for these hospitals/surgeons have been established. This review paper focuses on current status of bone/cartilage tissue engineering towards clinical applications in Japan.
authors.forename: Hajime
authors.initials: H
authors.lastname: Ohgushi
mesh_terms: D001842:Bone and Bones; D002356:Cartilage; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation; D023822:Tissue Engineering / Q000379:methods*